| Entry |
|
|---|
| Name |
Ethionamide (JP18/USP/INN);
Trecator (TN) |
|---|
| Abbr |
ETO |
|---|
| Product |
|
|---|
| Formula |
C8H10N2S
|
|---|
| Exact mass |
166.0565
|
|---|
| Mol weight |
166.2434
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 6224 |
|
|---|
| Efficacy |
Antibacterial (tuberculostatic) |
|---|
| Disease |
|
|---|
| Comment |
Thiocarbamide derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AD Thiocarbamide derivatives
J04AD03 Ethionamide
D00591 Ethionamide (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Ethionamide
D00591 Ethionamide (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
622 Tuberculosis preparations
6224 Ethionamides
D00591 Ethionamide (JP18/USP/INN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
DG01788 Thiocarbamide derivative
D00591 Ethionamide
Antimicrobials [BR:br08307]
Antibacterials
Other antibacterials
Mycolic acid biosynthesis inhibitor
D00591 Ethionamide (JP18/USP/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Other antibacterials
Mycolic acid biosynthesis inhibitor
D00591 Ethionamide (JP17/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00591 Ethionamide
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C8y C 22.9768 -17.0041
2 C8x C 21.7643 -17.7035
3 C8x C 22.9768 -15.6052
4 C2c C 24.1833 -17.7035
5 C8y C 20.5461 -17.0041
6 C8x C 21.7643 -14.9000
7 N1a N 25.3897 -17.0041
8 S0 S 24.1717 -19.1024
9 N5x N 20.5461 -15.6052
10 C1b C 19.3338 -17.7035
11 C1a C 18.1213 -17.0041
BOND 11
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 4 8 2
8 5 9 1
9 5 10 1
10 10 11 1
11 6 9 2
|
|---|
